Short answer · Medically reviewed summary · Last updated: 2023-07-13
Spinocerebellar ataxia (SCA) is a group of genetic disorders characterized by progressive degeneration of the cerebellum and its connections. It leads to impaired coordination, balance, and speech, affecting the quality of life for individuals affected by this condition. The prevalence of SCA varies depending on the specific subtype.
What is the prevalence of Spinocerebellar ataxia?
Prevalence of Spinocerebellar ataxia: how many people are affected worldwide, differences by sex and region, with sources.
Spinocerebellar ataxia (SCA) is a group of genetic disorders characterized by progressive degeneration of the cerebellum and its connections. It leads to impaired coordination, balance, and speech, affecting the quality of life for individuals affected by this condition.
The prevalence of SCA varies depending on the specific subtype. Overall, SCA is considered a rare disease, with an estimated prevalence of approximately 1 to 5 cases per 100,000 individuals worldwide. However, it is important to note that the prevalence may vary among different populations and regions.
There are multiple subtypes of SCA, each caused by a different genetic mutation. Some subtypes are more common than others. For instance, SCA3, also known as Machado-Joseph disease, is the most prevalent subtype globally, particularly in certain regions such as Portugal and Brazil. Other subtypes, such as SCA1 and SCA2, are less common but still contribute to the overall prevalence of SCA.
Due to the progressive nature of the disease, early diagnosis and appropriate management are crucial in improving the quality of life for individuals with SCA. Ongoing research aims to better understand the genetic basis of SCA and develop potential treatments to slow down or halt disease progression.
